Global Diuretic Drugs Market 2022-2026

PUBLISHED: June 26, 2022

PAGES: 120 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

Technavio has been monitoring the diuretic drugs market and it is poised to grow by $ 95.64 million during 2022-2026, accelerating at a CAGR of 5.44% during the forecast period. Our report on the diuretic drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of hypertension among people, increasing drug distribution through online channels, and increasing geriatric population.

The diuretic drugs market analysis includes the product type segment and geographic landscape.

Technavio's diuretic drugs market is segmented as below:

By Product Type

Loop diuretics
Thiazide diuretics
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing kidney diseases as one of the prime reasons driving the diuretic drugs market growth during the next few years. Also, the development of oral nanoparticle delivery mechanism and increased high investments in R&D activities in diuretics will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on diuretic drugs market covers the following areas:

Diuretic drugs market sizing
Diuretic drugs market forecast
Diuretic drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading diuretic drugs market vendors that include AbbVie Inc., Akorn Inc., Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Aurobindo Pharma Ltd., Bausch Health Companies Inc., Casper Pharma, Hikma Pharmaceuticals Plc, Lannett Co. Inc., Monarch Pharmachem, Novartis AG, Padagis US LLC, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Validus Pharmaceuticals LLC, VITARIS AG, and Zydus Lifesciences Ltd. Also, the diuretic drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR73814

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product Type

5.1 Market segments
Exhibit 24: Chart on Product Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Product Type - Market share 2021-2026 (%)
5.2 Comparison by Product Type
Exhibit 26: Chart on Comparison by Product Type
Exhibit 27: Data Table on Comparison by Product Type
5.3 Loop diuretics - Market size and forecast 2021-2026
Exhibit 28: Chart on Loop diuretics - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Loop diuretics - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Loop diuretics - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Loop diuretics - Year-over-year growth 2021-2026 (%)
5.4 Thiazide diuretics - Market size and forecast 2021-2026
Exhibit 32: Chart on Thiazide diuretics - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Thiazide diuretics - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Thiazide diuretics - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Thiazide diuretics - Year-over-year growth 2021-2026 (%)
5.5 Others - Market size and forecast 2021-2026
Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by Product Type
Exhibit 40: Market opportunity by Product Type ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Denmark - Market size and forecast 2021-2026
Exhibit 66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
7.9 China - Market size and forecast 2021-2026
Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
7.10 Canada - Market size and forecast 2021-2026
Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.11 India - Market size and forecast 2021-2026
Exhibit 78: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on India - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 85: Overview on factors of disruption
9.4 Industry risks
Exhibit 86: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 87: Vendors covered
10.2 Market positioning of vendors
Exhibit 88: Matrix on vendor position and classification
10.3 AbbVie Inc.
Exhibit 89: AbbVie Inc. - Overview
Exhibit 90: AbbVie Inc. - Product / Service
Exhibit 91: AbbVie Inc. - Key offerings
10.4 Alembic Pharmaceuticals Ltd.
Exhibit 92: Alembic Pharmaceuticals Ltd. - Overview
Exhibit 93: Alembic Pharmaceuticals Ltd. - Product / Service
Exhibit 94: Alembic Pharmaceuticals Ltd. - Key offerings
10.5 Aurobindo Pharma Ltd.
Exhibit 95: Aurobindo Pharma Ltd. - Overview
Exhibit 96: Aurobindo Pharma Ltd. - Product / Service
Exhibit 97: Aurobindo Pharma Ltd. - Key offerings
10.6 Hikma Pharmaceuticals Plc
Exhibit 98: Hikma Pharmaceuticals Plc - Overview
Exhibit 99: Hikma Pharmaceuticals Plc - Business segments
Exhibit 100: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 101: Hikma Pharmaceuticals Plc - Segment focus
10.7 Novartis AG
Exhibit 102: Novartis AG - Overview
Exhibit 103: Novartis AG - Business segments
Exhibit 104: Novartis AG - Key offerings
Exhibit 105: Novartis AG - Segment focus
10.8 Pfizer Inc.
Exhibit 106: Pfizer Inc. - Overview
Exhibit 107: Pfizer Inc. - Product / Service
Exhibit 108: Pfizer Inc. - Key news
Exhibit 109: Pfizer Inc. - Key offerings
10.9 Sun Pharmaceutical Industries Ltd.
Exhibit 110: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 111: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 112: Sun Pharmaceutical Industries Ltd. - Key offerings
10.10 Teva Pharmaceutical Industries Ltd.
Exhibit 113: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 114: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 115: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 116: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 117: Teva Pharmaceutical Industries Ltd. - Segment focus
10.11 Validus Pharmaceuticals LLC
Exhibit 118: Validus Pharmaceuticals LLC - Overview
Exhibit 119: Validus Pharmaceuticals LLC - Product / Service
Exhibit 120: Validus Pharmaceuticals LLC - Key offerings
10.12 VITARIS AG
Exhibit 121: VITARIS AG - Overview
Exhibit 122: VITARIS AG - Product / Service
Exhibit 123: VITARIS AG - Key offerings

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 124: Inclusions checklist
Exhibit 125: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 126: Currency conversion rates for US$
11.4 Research methodology
Exhibit 127: Research methodology
Exhibit 128: Validation techniques employed for market sizing
Exhibit 129: Information sources
11.5 List of abbreviations
Exhibit 130: List of abbreviations

Product Code: IRTNTR73814

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Product Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product Type
Exhibits27: Data Table on Comparison by Product Type
Exhibits28: Chart on Loop diuretics - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Loop diuretics - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Loop diuretics - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Loop diuretics - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Thiazide diuretics - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Thiazide diuretics - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Thiazide diuretics - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Thiazide diuretics - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Product Type ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: AbbVie Inc. - Overview
Exhibits90: AbbVie Inc. - Product / Service
Exhibits91: AbbVie Inc. - Key offerings
Exhibits92: Alembic Pharmaceuticals Ltd. - Overview
Exhibits93: Alembic Pharmaceuticals Ltd. - Product / Service
Exhibits94: Alembic Pharmaceuticals Ltd. - Key offerings
Exhibits95: Aurobindo Pharma Ltd. - Overview
Exhibits96: Aurobindo Pharma Ltd. - Product / Service
Exhibits97: Aurobindo Pharma Ltd. - Key offerings
Exhibits98: Hikma Pharmaceuticals Plc - Overview
Exhibits99: Hikma Pharmaceuticals Plc - Business segments
Exhibits100: Hikma Pharmaceuticals Plc - Key offerings
Exhibits101: Hikma Pharmaceuticals Plc - Segment focus
Exhibits102: Novartis AG - Overview
Exhibits103: Novartis AG - Business segments
Exhibits104: Novartis AG - Key offerings
Exhibits105: Novartis AG - Segment focus
Exhibits106: Pfizer Inc. - Overview
Exhibits107: Pfizer Inc. - Product / Service
Exhibits108: Pfizer Inc. - Key news
Exhibits109: Pfizer Inc. - Key offerings
Exhibits110: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits111: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits112: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits113: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits114: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits115: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits116: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits117: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits118: Validus Pharmaceuticals LLC - Overview
Exhibits119: Validus Pharmaceuticals LLC - Product / Service
Exhibits120: Validus Pharmaceuticals LLC - Key offerings
Exhibits121: VITARIS AG - Overview
Exhibits122: VITARIS AG - Product / Service
Exhibits123: VITARIS AG - Key offerings
Exhibits124: Inclusions checklist
Exhibits125: Exclusions checklist
Exhibits126: Currency conversion rates for US$
Exhibits127: Research methodology
Exhibits128: Validation techniques employed for market sizing
Exhibits129: Information sources
Exhibits130: List of abbreviations